Observation of Treatment Patterns With Lucentis in Approved Indications
CompletedOBSERVATIONAL
Enrollment
5,778
Participants
Timeline
Start Date
December 8, 2011
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Conditions
Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV